(Q53509178)
Statements
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. (English)
Butturini G
Bettini R
Missiaglia E
Mantovani W
Dalai I
Capelli P
Ferdeghini M
Pederzoli P
1 December 2006
13
4
1213-1221